Disabling those hinges could be a good strategy for designing vaccines and treatments against a broad range of coronavirus infections.

They aim to help society respond ten times faster with treatments for future disease outbreaks.

A molecule with hooks that can grip and disable the virus’s pesky protease shows potential for fighting infection.

Fan’s X-ray crystallography work at SLAC’s synchrotron moves us closer to a more protective coronavirus vaccine and a better understanding of how vital materials flow in and out of cells.

Powerful X-rays from SLAC’s synchrotron reveal that our immune system’s primary wiring seems to be no match for a brutal SARS-CoV-2 protein.

SLAC and Stanford scientists used it to zoom in on an iconic RNA catalyst and a piece of viral RNA that’s a potential target for COVID-19 treatments.

Two groups of researchers drew on SLAC tools to better understand how to target a key part of the virus that causes COVID-19.

Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature.

The study, done on a mild-mannered relative of the virus that causes COVID-19, paves the way for seeing more clearly how spike proteins initiate infections, with an eye to preventing and treating them.

The lab’s X-ray laser recently joined other facilities in making remote science possible from any corner of the world, a trend that will likely continue into the future.

Images reveal how some antibodies may block SARS-CoV-2 infection.

No human cell can function without these tiny machines, which cause disease when they go haywire and offer potential targets for therapeutic drugs.